|
| Dihydrodiol Ibrutinib Basic information |
Product Name: | Dihydrodiol Ibrutinib | Synonyms: | Dihydrodiol Ibrutinib;Ibrutinib iMpurity EQD;1-Propanone, 1-[(3R)-3-[4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2,3-dihydroxy-;Ibrutinib Impurity 3 (PCI-45227) (Mixture ofDiastereomers);Ibrutinib Dihydrodiol R-Isomer;Dihydrodiol Ibrutinib, PCI-45227;Ibrutinib Impurity 48;1-((R)-3-(4-amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl)piperidin-1-yl)-2,3-dihydroxypropan-1-one | CAS: | 1654820-87-7 | MF: | C25H26N6O4 | MW: | 474.51 | EINECS: | | Product Categories: | | Mol File: | 1654820-87-7.mol | |
| Dihydrodiol Ibrutinib Chemical Properties |
Melting point | >93°C (dec.) | Boiling point | 790.3±60.0 °C(Predicted) | density | 1.46±0.1 g/cm3(Predicted) | storage temp. | Hygroscopic, -20°C Freezer, Under inert atmosphere | solubility | Chloroform (Slightly), DMSO (Slightly), Methanol (Slightly) | pka | 13.13±0.20(Predicted) | form | Solid | color | White to Off-White | Stability: | Hygroscopic |
| Dihydrodiol Ibrutinib Usage And Synthesis |
Uses | Dihydrodiol Ibrutinib is a metabolite of Ibrutinib (I124970). Ibrutinib is a highly selective Bruton’s tyrosine kinase (Btk) irreversible inhibitor. |
| Dihydrodiol Ibrutinib Preparation Products And Raw materials |
|